# A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject

> **NCT01737931** · PHASE1 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Topical steroid (Dexamethasone)
- **DRUG:** Topical antihistamine (Diphenhydramine)

## Key facts

- **NCT ID:** NCT01737931
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01737931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01737931, "A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01737931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*